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Objectives: Iliopsoas muscle abscess (IPA) is considered a rare disease whose etiology has changed
depending on the country and antibiotic selection pressure. This study evaluates the changes in etiology,
clinical outcome, and risk factors for mortality for IPA.
Methods: We reviewed the medical records of a total of 116 patients with IPA who were admitted to 4
university hospitals in Korea over the 11 years, and compared the etiology between 2001 and 2006
(period 1, n ¼ 44) and 2007e2012 (period 2, n ¼ 72).
Results: Among 75 cases with a deﬁnitive microbial diagnosis, the predominant etiological organisms
were Staphylococcus aureus (45.3%), followed by Mycobacterium tuberculosis (14.7%) and Klebsiella
pneumoniae (9.3%). The percentage of MRSA in period 2 increased remarkably compared to period 1, from
25% to 44.4%, and incidence of M. tuberculosis from 7.1% to 19.1%, although these were not statistically
signiﬁcant. The overall mortality was 6.8% in period 1, and 13.9% in period 2, and sepsis as an initial
manifestation (OR 293.5, CI 7.1e12,034.4, P ¼ 0.003) and serum creatinine level (OR 0.43, CI 0.23e0.80,
P ¼ 0.008) were independent predictors of mortality. Invasive procedure improved the prognosis in cases
with microbiologic conﬁrmed pyogenic psoas abscess (46/50 [92%] vs. 9/14 [64.3%], P ¼ 0.008).
Conclusion: The incidence of MRSA as a cause of IPA is on the increase. Although the overall prevalence of
tuberculosis is decreasing, tuberculosis is still an important cause of IPA. Initial clinical status and
invasive intervention can lead to favorable outcomes.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Iliopsoas muscle abscess (IPA) refers to a purulent retroperito-
neal collection involving the iliopsoas muscle group.1 It is a rare
disease and there have been reported few data reports on IPA, all of
which are small case series. Traditionally, IPA has been character-
ized as primary IPAs developing through a hematogenous route and
secondary IPAs developing after the spread of infection from an
adjacent structure. The etiology of IPA may vary with each country
and time period.2 In the pre-antibiotics era, tuberculosis (TB) was
one of the most important pathogens in patients with IPA; however
the etiology of IPA has changedwith the decreasing of prevalence of
TB.1 In our study, we examined the epidemiology, clinical outcomepital, Department of Internal
, The Catholic University of
717, South Korea. Tel.: þ82 31
ciates Ltd. Published by Elsevier Ltand risk factors for mortality of IPA in Korea over a 11-year period,
and compared the etiology of IPA between 2001e2006 and 2007e
2012.
2. Materials and methods
We retrospectively reviewed the medical records of patients
who were diagnosed with IPA from 4 university hospitals in Korea
from January 2001 to May 2012. Patients were included if their
radiologic ﬁndings, observed using computed tomography or MRI,
were compatible with abscess in the psoas muscle, and clinical
symptoms and signs were compatible with infection. We analyzed
the clinical characteristics, laboratory ﬁndings, etiology and out-
comes of patients with IPA, and compared with the results between
years 2001e2006 (period 1) and 2007e2012 (period 2) year. Pri-
mary IPA was deﬁned as IPA resulting from hematogenous spread
from an occult source of infection. Secondary IPAwas deﬁned as IPA
spreading from an adjacent structure such as skeletal, gastroin-
testinal, genitourinary and skin and soft tissue.3 The differentiationd. All rights reserved.
Table 2
Distribution of origin of infection in 105 patients with pyogenic IPA.
Total
(n ¼ 105)
Period 1
(n ¼ 42)
Period 2
(n ¼ 63)
Primary IPA 41 (39.0%) 15 (35.7%) 26 (41.3%)
Secondary IPA 64 (60.9%) 27 (64.3%) 37 (58.3%)
Bone origin 22 (34.4%) 9 (33.3%) 13 (35.1%)
Spondylitis 14 6 8
Septic arthritis 5 2 3
Pelvic osteomyelitis 3 1 2
Intra-abdominal origin 21 (32.8%) 9 (33.3%) 12 (32.4%)
Intestinal perforation 8 4 4
Enteric ﬁstula 4 1 3
Crohn’s diseases 2 1 1
Diverticulitis 5 2 3
Necrotizing pancreatitis 2 1 0
Appendicitis 1 0 1
Urinary tract origin 15 (23.4%) 7 (25.9%) 8 (21.6%)
Pyelonephritis 12 6 6
Renal abscess 3 1 2
Skin soft tissue origin 5 (7.8%) 1 (3.7%) 4 (10.8%)
Necrotizing fasciitis 3 1 2
Wound infection 1 0 1
Sore 1 0 1
Vascular origin 1 (1.6%) 1 (3.7%)a 0 (0%)
In this table, we analyzed IPA patients excluding the TB cases.
a Infected hematoma.
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by two infectious disease specialists. Diagnosis of active TB was
based on current recommendations.4 Conﬁrmed TB was deﬁned as
positive culture results or PCR results and probable TB as (1) a
histological ﬁnding on a biopsy, such as caseous granuloma or
radiologic ﬁndings compatible with TB and (2) successful response
to anti-TB medication. Sepsis was deﬁned according to the previous
literature.5
This studywas approved by the institutional review board of the
Catholic University of Korea.
3. Statistically analysis
Student’s t-test was used for analysis of continuous variables,
and the chi-squared test or Fisher’s exact test was used for cate-
gorical variables. We analyzed the risk factors associated with
mortality using univariate and multivariate logistic regression an-
alyses. Statistical analysis was performed using SPSS 13.0 and a P
value <0.05 was considered statistically signiﬁcant.
4. Results
A total of 116 patients were enrolled, and the demographic
characteristics are shown in Table 1. The mean age was 58.5  1.6
years old, and 53 patients (54.3%) were male. The most common
predisposing factor was hypertension (30.2%), followed by diabetes
mellitus (29.3%) and malignancy (13.8%). A previous acupuncture
history within 3 months prior to admission was apparent in 12.9%.
The demographic characteristics were not different between period
1 and period 2. Table 2 shows the distribution of IPA according to
origin and the comparison by periods, excluding the TB cases.
Forty-one cases (39.0%) were primary IPA and among the 64 cases
with secondary IPA, skeletal infections were the most frequent
source of infection (n ¼ 22, 34.4%), followed by intra-abdominal
infection (n ¼ 21, 32.8%), urinary tract infection (n ¼ 15, 23.4%),
skin and soft tissue infection (n ¼ 5, 7.8%) and infected vascular
aneurysm (n ¼ 1, 1.6%). Of skeletal origin, spondylitis was the most
common diagnosis (n ¼ 14). Secondary IPA was observed more
often than primary IPA in both periods, and the percentage of cases
with secondary IPAwas not different between the 2 periods (27/42
[64.3%] in period 1 vs. 37/63 [58.3%] in period 2, P ¼ 0.57).
Positive blood cultures were obtained in 36.8% (42/114) and
abscess cultures in 67.1% (49/73). Among 75 cases in which a
deﬁnitive microbial diagnosis was identiﬁed, the predominant
etiological organisms were Staphylococcus aureus (45.3%, 34/75),
followed byMycobacterium tuberculosis (14.7%,11/75) and Klebsiella
pneumoniae (9.3%, 7/75). Of the 34 S. aureus cases, 35.3% were
methicillin-resistant S. aureus (MRSA). Fig. 1 shows the comparison
of microbial etiology of IPA between period 1 and period 2.
Microbiologically undiagnosed cases were 36.4% (16/44) in periodTable 1
Demographic characteristics.
Characteristics No. of patients
(n ¼ 116)
yPeriod 1
(n ¼ 44)
zPeriod 2
(n ¼ 72)
P-value
Age, years 58.5  1.6 56.2  17.4 59.8  18.2 0.29
Sex, male, n (%) 53 (54.3%) 23 (52.3%) 30 (41.7%) 0.27
Comorbid condition
Diabetes mellitus 34 (29.3%) 9 (20.5%) 25 (34.7%) 0.10
Hypertension 35 (30.2%) 10 (22.7%) 25 (34.7%) 0.17
Chronic liver disease 7 (6.0%) 5 (11.4%) 2 (2.8%) 0.06
Malignancy 16 (13.8%) 4 (9.1%) 12 (16.7%) 0.25
Dialysis 9 (7.8%) 5 (11.4%) 4 (5.6%) 0.26
Previous TB exposure 13 (11.2%) 4 (9.1%) 9 (12.5%) 0.57
Acupuncture history 15 (12.9%) 5 (11.4%) 10 (13.9%) 0.69
yPeriod 1: years 2001e2006, zPeriod 2 years 2007e2012.1, and 34.7% (25/72) in period 2. S. aureus was the most frequent
pathogens in both periods; however the accountable percentage of
S. aureus in period 2 among microbiologically diagnosed cases had
decreased comparedwith period 1 (57.1% [16/28] vs. 38.3% [18/47]).
In particular, MRSA in all S. aureus cases had increased remarkably
from 25% (4/16, period 1) to 44.4% (8/18, period 2); however this
increase was not statistically signiﬁcant (P¼ 0.23). The incidence of
M. tuberculosis had increased from 7.1% (2/28, period 1) to 19.1% (9/
47, period 2), and was still an important pathogen of IPA until
recently, although this changes was not signiﬁcant (P ¼ 0.15).
In patients with primary IPA, S. aureus was the predominant
pathogen and accounted approximately 47.8% (22/46) of cases.
Various organisms including 5 K. pneumoniae and 5 Escherichia coli
were detected in secondary IPA. Of eleven patients with psoas ab-
scess caused by M. tuberculosis, 9 cases were diagnosed as having
conﬁrmed TB (5 culture and 4 PCR), and 2 as probable TB. Addi-
tionally, 5 cases were diagnosed as disseminated TB. Resistance to
anti-TB medication was not found in culture-proven cases. The
percentage of previous TB exposure was signiﬁcantly higher in
patients with IPA due to M. tuberculosis than that due to other
pathogens (54.5% [6/11] vs. 6.7% [7/105], P < 0.001).
The overall mortality was more slightly higher in period 2 than
in period 1; however this difference was not statistically signiﬁcant
(6.8% [3/44] in period 1 vs. 13.9% [10/72] in period 2, P ¼ 0.24). Of a
total of 13 patients who had died, microbial diagnosis was
conﬁrmed in 69.2% (9/13) and S. aureus was the leading cause of
death in 5 patients. Table 3 shows the comparison of the charac-
teristics between the surviving (n ¼ 103) and deceased (n ¼ 13)
patients. Mortality cases received more dialysis as an underlying
disease (30.8% vs. 4.9%, P¼ 0.001), showed higher serum creatinine
level (2.8  3.4 vs. 1.1  0.8 mg/dl, P ¼ 0.01) and C-reactive protein
levels (25.0  24.2 vs. 13.2  10.1 mg/dl, P ¼ 0.01) than survivor
cases. Patients who were admitted to the hospital due to sepsis
showed higher mortality (P ¼ 0.0001). The abscess size was larger
in themortality cases than in the survivor cases, however this is not
signiﬁcantly different (8.4  4.1 vs. 6.9  3.9, P ¼ 0.41). Univariate
analysis revealed that dialysis as an underlying disease, sepsis as an
initial manifestation (OR 4.47, CI 9.20e830.54, P ¼ 0.0001), serum
creatinine level (OR 0.59, CI 0.39e0.89, P ¼ 0.01) and C-reactive
protein level (OR 0.95, CI 0.91e0.99, P ¼ 0.01) were signiﬁcant
Fig. 1. Microbiological etiology according to the periods among microbiologically conﬁrmed cases. Period 1: years 2001e2006, period 2: years 2007e2012. MRSA; methicillin-
resistant S. aureus, MSSA; methicillin-sensitive S. aureus, TB; tuberculosis.
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mortality were sepsis as an initial manifestation (OR 293.5, CI 7.1e
12,034.4, P ¼ 0.003) and serum creatinine level (OR 0.43, CI 0.23e
0.80, P ¼ 0.008). Treatment included antibiotics alone for 33
(28.4%), antibiotics plus percutaneous drainage for 29 (25%), and
antibiotics plus surgery for 54 (46.6%) of the 116 patients. Treat-
ment modality was not associated with the mortality (Table 4),
however, subgroup analysis (n ¼ 64) for microbiologically
conﬁrmed pyogenic IPA cases, excluding M. tuberculosis, patients
who performed invasive procedures, including percutaneous
drainage or surgery, showed signiﬁcantly favorable outcomes as
compared to those who received only antibiotics (46/50 [92%] vs. 9/
14 [64.3%], P ¼ 0.008). Abscess size and the presence of bacteremia
were not associated with the mortality in multivariate analysis
(Table 4).
5. Discussion
IPA is a rare disease and thus far, only IPA reports of small case
series have been published.6e8 This current study demonstrates the
etiology, treatment and clinical outcome of 116 patients with IPA in
Korea, and this constitutes a relatively large case series. In the pre-Table 3
Comparison of characteristics between surviving and deceased patients.
Characteristics Survival (n ¼ 103) Mortality (n ¼ 13) P-value
Age, years 57.7  18.3 64.4  13.7 0.2
Sex, male 47 (45.6%) 6 (46.2%) 0.97
Diabetes mellitus 31 (30.1%) 3 (23.1%) 0.60
Malignancy 13 (12.6%) 3 (23.1%) 0.30
Dialysis 5 (4.9%) 4 (30.8%) 0.001
S. aureus as an etiology 29 (28.2%) 5 (38.5%) 0.44
Microbial conﬁrmed 66 (64.1%) 9 (69.2%) 0.71
Hospital day to diagnosis, days 3.9  8.4 2.5  3.7 0.57
White blood cell, mm3 14,002  6906 13.796  7185 0.92
Platelet, mm3 21,078  69,800 9328  32,378 0.56
Creatinine, mg/dl 1.1  0.8 2.8  3.4 0.01
ESR, mm/h 66.7  31.9 61.3  39.7 0.60
C-reactive protein, mg/dl 13.2  10.1 25.0  24.2 0.01
Presence of bacteremia 35 (34.7%) 7 (53.8%) 0.30
Sepsis as an initial manifestation 1 (1.0%) 6 (46.2%) 0.0001
Invasive procedurea 76 (73.8%) 7 (53.8%) 0.13
Abscess size, cm 6.9  3.9 8.4  4.1 0.41
a Invasive procedure includes percutaneous drainage and surgery.antibiotic era, TB was known to be one of the most common
complications in patients with IPA, especially in cases of Pott’s
disease. There is an increasing trend of pyogenic psoas abscess,
while the incidence of TB is decreasing worldwide.9e11 One study,
including 24 patients with IPA from 1996 to 2001 in Korea showed
that S. aureus (n ¼ 7) was the most frequent pathogen, followed by
M. tuberculosis (n ¼ 6), and more methicillin-sensitive S. aureus
strains (77.8%, 7/9) were identiﬁed than MRSA (28.5%, 2/7).12 In our
present study, since 2001, S. aureus was the most important path-
ogen of IPA, and the percentage of MRSA was slightly increased at
35.3% compared with the previous data.12 According to the periods,
the percentage of MRSA in 2007e2012 increased remarkably
compared to 2001e2006, from 25% to 44.4%, although this increase
was not statistically signiﬁcant. There was one report on the in-
crease in MRSA as the leading cause of IPA, and this change may be
due to several reasons including increasing immunocompromised
hosts, drug resistant organisms and repeat surgery.13
Our study also showed that a large percentage of IPA consisted
of M. tuberculosis in Korea until recently. The percentage of TB
among microbiologically conﬁrmed cases in 2007e2012 increased
compared to 2001e2006, although this increase was not statisti-
cally signiﬁcant. Korea is still intermediate TB risk area, where newTable 4
Risk factors for mortality.
Univariate analysis Multivariate analysis
OR 95% CI P-value OR 95% CI P-value
Age 0.97 0.94e1.0 0.20
Diabetes mellitus 1.44 0.37e5.57 0.60
Dialysis 8.71 1.98e38.32 0.004 7.95 0.18e339.03 0.28
Sepsis as an initial
manifestation
4.47 9.20e830.54 0.0001 293.5 7.1e12,034.4 0.003
Invasive
procedure
0.59 0.18e1.98 0.39
White blood cell
count
0.99 0.99e1.01 0.92
Platelet 1.01 0.98e1.02 0.56
Creatinine 0.59 0.39e0.89 0.01 0.43 0.23e0.80 0.008
C-reactive protein 0.95 0.91e0.99 0.01 0.95 0.89e1.00 0.06
Presence of
bacteremia
2.2 0.69e7.05 0.18
Abscess size 0.92 0.74e1.13 0.41
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although the downward trend of incidence continues.14 In addition,
it is interesting that disseminated TB cases, which spread hema-
togenously from lung, were found to be as high as 45.4% (5/11). In
studies from Spain and Turkey, most tuberculous cases were
considered secondary IPA.15,16 The high prevalence of TB in the
etiology of IPA, especially disseminated TB cases, reﬂects this public
health problem, and serves to highlight the importance of TB
control to help reduce transmission in Korea. Our study indicated
that IPA due to M. tuberculosis was more common in patients with
previous TB exposure andwe should consider TB as a cause of IPA in
patients with previous TB exposure in TB intermediate-risk areas
such as Korea. It is well known that latent TB can develop active
disease in 10% of persons in a lifetime.17
The advances in intervention and effective antimicrobial ther-
apy have improved survival of patients with IPA, and several recent
studies report an IPA mortality of approximately 5%.15,18 It is difﬁ-
cult to analyze the risk factors for mortality in IPA patients because
of the rarity of IPA. There are few studies about risk factors, but
some have reported that bacteremia, older age and comorbidity
were associated with mortality in patients with IPA.15,18 In our
study, in-hospital mortality was as high as 11.2%, and the risk fac-
tors associated with mortality in IPA patients were sepsis as an
initial manifestation and high serum creatinine levels. Therefore
the clinical status at the time of admission affects the outcome in
patients with IPA.
It is well known that source control is of importance in cases of
intra-abdominal infection.19 Surgical drainage and intestinal
resection are beneﬁcial if the origin of IPA is Crohn’s disease, and
percutaneous drainage is considered to be a good option with a
success rate of 90% after it was ﬁrst described in 1984.20e22 There
was a report that patients with small abscesses responded well to
antibiotics alone, and in our study, patients with a small size of IPA
or who performed invasive procedure showed favorable
outcome.23 Therefore, we should consider invasive drainage espe-
cially for patients with for large sized pyogenic IPA.
Our study has some limitations. First, this is a retrospective
study including 116 cases of IPA. However, IPA has been described
globally as a rare disease, and this study includes relatively large
cases series culled over 10 years in Korea. Second, this study does
not evaluate the appropriate antimicrobial effect on outcome, and
further studies will be needed. Third, it is difﬁcult to differentiate
between primary and secondary IPA, and so we arbitrate the
opinion by two infectious disease specialists.
In conclusion, S. aureus from skeletal source is still the most
prevalent microorganism of IPA and MRSA shows an increased
tendency to occur in IPA patients in Korea. Although the overall
prevalence of TB is decreasing, TB is still considered to be an
important cause of IPA. Initial clinical status and invasive inter-
vention can lead to favorable outcomes.
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